Clinical trial
Proviral DNA as a Target for HIV-1 Resistance Analysis
NCT04088916 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proviral DNA as a Target for HIV-1 Resistance Analysis
- Lead sponsor
- University of Chile
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 15, 2018
- Completion date
- December 31, 2022
- Enrollment
- 1,200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, hiv seropositivity, hiv/aids, viral infection